Brokerage firm Motilal Oswal has initiated coverage on Sagility India with a target price of Rs 54. Analysts expect the healthcare services provider to see strong revenue and profit growth through fiscal year 2028, driven by new client wins and technology integration.
Motilal Oswal Financial Services has started tracking Sagility India, assigning a target price of Rs 54 per share. The brokerage firm holds a positive outlook on the company, forecasting significant financial expansion over the next few years.
According to the research note, analysts expect Sagility to achieve a 19% average annual growth rate in both revenue and operating profit (EBITDA) through fiscal year 2028. They also project that net profit will grow at an annual rate of 23% during the same period.
Growth Strategy and Drivers
The brokerage's stance is based on Sagility’s position in the niche healthcare business process management (BPM) sector. The company primarily serves US-based healthcare payers, such as insurance companies, and providers, including hospitals and clinics. Analysts believe Sagility can improve its financial performance by winning new client contracts and successfully cross-selling additional services to its existing customer base.
The integration of recent acquisitions and the use of advanced technology, such as artificial intelligence, are identified as key drivers for this growth. The company aims to differentiate itself by combining specialized healthcare knowledge with technical platforms to manage complex administrative tasks for its clients. The target price of Rs 54 is calculated using an 18x multiple on the company's estimated earnings per share for fiscal year 2028, reflecting confidence in its ability to scale operations.
Risks and Monitorables
While the outlook focuses on growth, investors in the healthcare outsourcing sector often track specific business risks. Sagility’s business model is heavily dependent on the US healthcare market, which makes the company sensitive to changes in American government regulations, healthcare policies, and overall US healthcare spending.
Furthermore, companies in this sector often face client concentration risk, meaning a significant portion of total revenue may come from a small number of large customers. Any changes in these key client relationships or a delay in service delivery could impact the company's performance. Moving forward, investors will likely track the company’s ability to successfully integrate its acquisitions, maintain profit margins while scaling, and manage the competitive environment in the US healthcare service market.